In the press
Michigan BioSocial
Michigan BioSocial
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities
Related Press
Orange Grove Bio Establishes Partnership with Albert Einstein College of Medicine
Orange Grove Bio Establishes Partnership with Albert Einstein College of Medicine The following excerpt was taken from Globe Newswire — continue reading here. Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration and growth “Orange Grove Bio, AlleyCorp and Alexandria Venture Investments, three industry leaders dedicated to the acceleration
IpiNovyx Bio closes $10 million seed financing round
IpiNovyx Bio closes $10 million seed financing round The below is an excerpt taken from EndPoints News about our portfolio company, Ipinovyx Bio. The following excerpt was taken from EndPonts News — continue reading here. “With a focus on autoimmune and inflammatory diseases, IpiNovyx Bio closed a $10 million seed financing round “With a focus
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio
Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio The following was taken from PR Newswire and you can read it here: https://www.prnewswire.com/news-releases/research-bridge-partners-seed-capital-investment-in-asalyxa-bio-advances-dr-lola-eniola-adefesos-immune-cell-targeted-therapeutic-platform-301242853.html “Research Bridge Partners – a 501 (c) (3) organization that bridges preeminent innovators at mid-continent research universities AUSTIN, Texas, March 9, 2021 /PRNewswire/ — Research Bridge Partners – a 501 (c) (3)
Orange Grove Bio Appoints Key Leadership & New Academic Collaboration
The University of Pittsburgh and Orange Grove Bio Establish Partnership… The following excerpt was taken from Globe Newswire — continue reading here. Orange Grove Bio, a preclinical drug investment and development firm, today announced several key leadership appointments highlighted by its naming John C. Byrd, M.D. Orange Grove Bio, a preclinical drug investment and development
IpiNovyx Bio Closes on $10 Million Seed Financing Round to Advance Proprietary Platform
IpiNovyx Bio Closes on $10 Million Seed Financing Round to Advance Proprietary Platform The following excerpt was taken from Trialsitenews — continue reading here. IpiNovyx Bio Closes on $10 Million Seed Financing Round to Advance Proprietary Platform “New York-based IpiNovyx Bio announced the closing of a $10 million seed financing round. The financing was led
Orange Grove Bio Subsidiary Awarded $2.05 Million SBIR Phase II Grant to Advance Development of Novel Platelet Preservation Technology
OGB Also Announces Key Appointments to Board of Senior Advisors and the Opening of New Headquarters The following excerpt was taken from GlobeNewswire – continue reading here. CINCINNATI, Sept. 28, 2023 (GLOBE NEWSWIRE) Orange Grove Bio (OGB), a drug investment and development firm, today announced that Preservation Bio, one of the firm’s majority-owned subsidiaries, has been
Orange Grove Bio Sets Sights on Rapidly Emerging Middle East Biotech Ecosystem through New Academic Collaboration with Weizmann Institute of Science
Partnership represents firm’s second international collaboration and provides access to groundbreaking research taking place within world’s fifth largest pharmaceutical market The following excerpt was taken from GlobeNewswire – continue reading here. CINCINNATI, January 31, 2023 (GLOBE NEWSWIRE) – Orange Grove Bio, a drug investment and development firm, today announced that it has established a new
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities on April 16th at 1 PM EST.
Upcoming Webinar for Pre-Clinical Biotech Development Opportunities on April 16th at 1 PM EST. Please join us to hear from our CEO, Marc Appel.– continue reading here. Upcoming Webinar for Pre-Clinical Biotech Development Opportunities
Wall Street Journal
Wall Street Journal The following was taken from the Wall Street Journal. Check out the original piece here: https://www.wsj.com/articles/vc-daily-biotechs-test-new-company-building-model-11614261635 We are incredibly excited and humbled to be recognized in the Wall Street Journal for our innovative business model! We thank everyone who has been supporting us from the beginning.